Swedish snuff, better known as 'snus,' was found not to increase a person's risk of developing multiple sclerosis.
Cigarettes, Not Swedish Snuff, Linked to MS Risk.
While smoking cigarettes appears to significantly increase a person’s risk of developing multiple sclerosis, using Swedish snus does not, according to a study published in Neurology, the medical journal of the American Academy of Neurology.
“While tobacco cigarettes increased a person’s risk of developing MS, our research found that using Swedish snus was not associated with an elevated risk for MS,” said study author Anna Hedström, MD, of the Swedish medical university Karolinska Institutet in Stockholm. ”These results could mean that nicotine is not the substance responsible for the increased risk of MS among smokers.”
The study involved 902 people diagnosed with MS and 1,855 people without MS in Sweden between the ages of 16 and 70. All participants answered a questionnaire about tobacco, cigarettes and snus use.
The researchers found that in women who smoked, the risk for developing MS was nearly one and a half times higher than in women who did not smoke. In men, the risk was nearly two times higher in those who smoked compared to those who did not smoke. This was the case even in people who only smoked moderately.
The risk remained high for up to five years after the participant stopped smoking and the risk climbed the more a person smoked. However, the study also found that people who used Swedish snus for more than 15 years were 70 percent less likely to develop MS than those who had never used any type of tobacco. However, there was no significant effect of snus-taking for less than 15 years, a period during which other adverse consequences of taking snus would become evident.
The study was supported by The Swedish Medical Research Council, the Swedish Council for Working Life and Social Research, the European Union’s Sixth Framework Program NeuroproMiSe, Bibbi and Niels Jensens Foundation, Montel Williams Foundation and the Söderberg Foundation.
Source: www.aan.com /American Academy of Neurology